[HTML] mdpi.com

[HTML][HTML] A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk …

J Liu, J Santucci, DTS Woon, R Catterwell, M Perera… - Life, 2024 - mdpi.com
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …
被引用次数：3 相关文章

A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk Prostate …

J Liu, J Santucci, DTS Woon, R Catterwell… - Life (2075 …, 2024 - search.ebscohost.com
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …
[HTML] nih.gov

[HTML][HTML] A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk …

J Liu, J Santucci, DTS Woon, R Catterwell, M Perera… - Life, 2024 - ncbi.nlm.nih.gov
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …

A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk Prostate …

J Liu, J Santucci, DTS Woon… - Life (Basel …, 2024 - pubmed.ncbi.nlm.nih.gov
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …

A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk Prostate …

J Liu, J Santucci, DTS Woon, R Catterwell, M Perera… - Life, 2024 - search.proquest.com
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …

A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk Prostate …

J Liu, J Santucci, DTS Woon, R Catterwell… - Life (Basel …, 2024 - europepmc.org
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …

A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk Prostate …

J Liu, J Santucci, DTS Woon, R Catterwell, M Perera… - Life (Basel), 2024 - go.gale.com
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …

A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk Prostate …

J Liu, J Santucci, DTS Woon, R Catterwell, M Perera… - Life, 2024 - ui.adsabs.harvard.edu
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …

A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk Prostate …

J Liu, J Santucci, DTS Woon, R Catterwell… - Life (Basel …, 2024 - europepmc.org
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …